Search Results

You are looking at 51 - 60 of 614 items for :

  • "surveillance" x
Clear All
Full access

Anthony J. Olszanski

therapy restricted to diseases for which specific mutations elicit a response,” he proposed. Immune Surveillance, Evasion, and Suppression The immunoediting hypothesis has 3 phases: the elimination phase, which consists of active immune

Full access

J. Sybil Biermann, Douglas R. Adkins, Mark Agulnik, Robert S. Benjamin, Brian Brigman, James E. Butrynski, David Cheong, Warren Chow, William T. Curry, Deborah A. Frassica, Frank J. Frassica, Kenneth R. Hande, Francis J. Hornicek, Robin L. Jones, Joel Mayerson, Sean V. McGarry, Brian McGrath, Carol D. Morris, Richard J. O'Donnell, R. Lor Randall, Victor M. Santana, Robert L. Satcher, Herrick J. Siegel, Margaret von Mehren, Mary Anne Bergman and Hema Sundar

with demonstrated expertise in the management of these tumors. Long-term surveillance and follow-up are necessary when considering the risk of recurrence and comorbidities associated with chemotherapy and radiation therapy (RT). Life-long follow-up is

Full access

George L. Jackson, Leah L. Zullig, S. Yousuf Zafar, Adam A. Powell, Diana L. Ordin, Ziad F. Gellad, David Abbott, James M. Schlosser, Janis Hersh and Dawn Provenzale

on the timeliness of CRC care. 4 , 5 This measurement tool was developed to evaluate the continuum of CRC care, from diagnosis through treatment and surveillance. Although the existence of this tool was previously noted as part of summaries of the

Full access

Dawn Provenzale, Samir Gupta, Dennis J. Ahnen, Travis Bray, Jamie A. Cannon, Gregory Cooper, Donald S. David, Dayna S. Early, Deborah Erwin, James M. Ford, Francis M. Giardiello, William Grady, Amy L. Halverson, Stanley R. Hamilton, Heather Hampel, Mohammad K. Ismail, Jason B. Klapman, David W. Larson, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, Reid M. Ness, Scott E. Regenbogen, Niloy Jewel Samadder, Moshe Shike, Gideon Steinbach, David Weinberg, Mary Dwyer and Susan Darlow

syndrome, surveillance (particularly for first or metachronous CRC) offers an opportunity for early detection and perhaps even prevention of cancer among mutation carriers. Further, cancer site-specific evaluation and heightened attention to symptoms is

Full access

David S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila A. Bazhenova, Hossein Borghaei, David Ross Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Thomas Dilling, Michael Dobelbower, Ramaswamy Govindan, Mark Hennon, Leora Horn, Thierry M. Jahan, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Rogerio Lilenbaum, Jules Lin, Billy W. Loo Jr, Renato Martins, Gregory A. Otterson, Jyoti D. Patel, Katherine M. Pisters, Karen Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Neelesh Sharma, Scott J. Swanson, James Stevenson, Kurt Tauer, Stephen C. Yang, Kristina Gregory and Miranda Hughes

. Meyerhoff RR Yang CF Speicher PJ . Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database . J Surg Res 2015 ; 196 : 23 – 32 . 6. Musk AW Olsen N Alfonso H . Predicting survival in

Full access

Samir Gupta, Dawn Provenzale, Xavier Llor, Amy L. Halverson, William Grady, Daniel C. Chung, Sigurdis Haraldsdottir, Arnold J. Markowitz, Thomas P. Slavin Jr, Heather Hampel, CGC, Reid M. Ness, Jennifer M. Weiss, Dennis J. Ahnen, Lee-may Chen, Gregory Cooper, Dayna S. Early, Francis M. Giardiello, Michael J. Hall, Stanley R. Hamilton, Priyanka Kanth, Jason B. Klapman, Audrey J. Lazenby, Patrick M. Lynch, Robert J. Mayer, June Mikkelson, CGC, Shajan Peter, Scott E. Regenbogen, Mary A. Dwyer, CGC and Ndiya Ogba

surveillance and management for affected individuals. 6 High-risk individuals may be identified based on phenotypic criteria, including family history and patient-specific factors, such as age at diagnosis and tumor phenotype. The presence of a genetic

Full access

Guadalupe R. Palos, Katherine Gilmore, Patricia Chapman, Weiqi Bi, Paula Lewis-Patterson and Alma Maria Rodriguez

Background: NCCN Guidelines recommend annual mammography for surveillance in asymptomatic women diagnosed with breast cancer. There is limited evidence to support which type of mammogram—screening or diagnostic—should be ordered for asymptomatic

Full access

Mariam Naveed, Meredith Clary, Chul Ahn, Nisa Kubiliun, Deepak Agrawal, Byron Cryer, Caitlin Murphy and Amit G. Singal

reasons, including surveillance of those with prior adenomas and for diagnostic evaluation of patients with gastrointestinal symptoms. In fact, diagnostic and surveillance colonoscopies account for most endoscopy examinations performed in the United States

Full access

Erin Reid, Gita Suneja, Richard F. Ambinder, Kevin Ard, Robert Baiocchi, Stefan K. Barta, Evie Carchman, Adam Cohen, Oxana V. Crysler, Neel Gupta, Chelsea Gustafson, Allison Hall, Kimberly L. Johung, Ann Klopp, Ann S. LaCasce, Chi Lin, Amitkumar Mehta, Manoj P. Menon, David Morgan, Nitya Nathwani, Ariela Noy, Lee Ratner, Stacey Rizza, Michelle A. Rudek, Julian Sanchez, Jeff Taylor, Benjamin Tomlinson, Chia-Ching J. Wang, Sai Yendamuri, Mary A. Dwyer, CGC and Deborah A. Freedman-Cass

Anderson Cancer Center revealed, however, that the rate of HIV testing from 2007 to 2009 was only 19.3%. 25 Analysis of data from the 2009 Behavioral Risk Factor Surveillance System showed that 41% of U.S. cancer survivors <65 years of age reported ever

Full access

Carlo C. Maley and Anil K. Rustgi

. Hospital volume and surgical mortality in the United States . N Engl J Med 2002 ; 346 : 1128 – 1137 . 16. Sampliner RE . Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus . Am J Gastroenterol 2002 ; 97